Skip to search.
 TSX Up 0.65% TSX Ventures Down 0.16%

Neuralstem, Inc. (CUR)

-NYSE MKT
1.95 Down 0.06(2.99%) Mar 30, 4:00PM EDT
|Pre-Market : 1.93 7:19PM EDT
Add to Portfolio
Prev Close:2.01
Open:2.00
Bid:1.84 x 10000
Ask:2.42 x 400
1y Target Est:4.13
Beta:2.2
Earnings Date:May 11 - May 15 (Est.)
Day's Range:1.87 - 2.01
52wk Range:1.78 - 4.81
Volume:1,069,700
Avg Vol (3m):1,439,140
Market Cap:174.92M
P/E (ttm):N/A
EPS (ttm):-0.26
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CURDown 2.99%174.92M
GERNUp 0.52%610.30M
STEMUp 4.25%71.37M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9,573.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.29
Quarterly EPS Est (Mar-15) :-0.06
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of regenerative medicine treatments based on its human neuronal stem cells and small molecule compounds. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback